The Double-Trunk Mask Improves Oxygenation During High-Flow Nasal Cannula Therapy for Acute Hypoxemic Respiratory Failure.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 2 5 2019
medline: 1 7 2020
entrez: 2 5 2019
Statut: ppublish

Résumé

High-flow nasal cannula (HFNC) oxygen therapy is used to deliver an F We report a prospective multi-center crossover pilot study including 15 subjects treated with HFNC for acute hypoxemic respiratory failure. Measurements were performed at the end of 30-min periods with HFNC only, with HFNC + DTM, and again with HFNC only. Compared with HFNC alone, HFNC + DTM increased P In subjects receiving oxygen via HFNC, the addition of the DTM over the HFNC increased P

Sections du résumé

BACKGROUND BACKGROUND
High-flow nasal cannula (HFNC) oxygen therapy is used to deliver an F
METHODS METHODS
We report a prospective multi-center crossover pilot study including 15 subjects treated with HFNC for acute hypoxemic respiratory failure. Measurements were performed at the end of 30-min periods with HFNC only, with HFNC + DTM, and again with HFNC only.
RESULTS RESULTS
Compared with HFNC alone, HFNC + DTM increased P
CONCLUSION CONCLUSIONS
In subjects receiving oxygen via HFNC, the addition of the DTM over the HFNC increased P

Identifiants

pubmed: 31040207
pii: respcare.06520
doi: 10.4187/respcare.06520
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

908-914

Informations de copyright

Copyright © 2019 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Frédéric Duprez (F)

ICU, Epicura Hospital, Hornu, Belgium, the Institut de Recherche Expérimentale et Clinique (IREC), Pole de Pneumologie, ORL & Dermatologie, Service de Pneumologie, Université Catholique de Louvain, Brussels, Belgium, and the Laboratoire de l'Effort et du Mouvement Condorcet, Tournai, Belgium. frederic.duprez@epicura.be.

Arnaud Bruyneel (A)

Intensive Care Unit, Université Catholique de Louvain, Brussels, Belgium, and the Haute Ecole Provinciale Condorcet, Mons, Belgium.

Shahram Machayekhi (S)

ICU, Epicura Hospital, Hornu, Belgium.

Marie Droguet (M)

ICU, Tivoli Hospital, La Louvière, Belgium.

Yves Bouckaert (Y)

ICU, Tivoli Hospital, La Louvière, Belgium.

Serge Brimioulle (S)

Department of Intensive Care, Erasme Hospital, Brussels, Belgium.

Gregory Cuvelier (G)

Laboratoire de l'Effort et du Mouvement Condorcet, Tournai, Belgium.

Gregory Reychler (G)

Institut de Recherche Expérimentale et Clinique (IREC), Pole de Pneumologie, ORL & Dermatologie, Service de Pneumologie, Université Catholique de Louvain, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH